Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1950 4
1951 2
1952 1
1953 3
1954 3
1955 3
1956 4
1957 3
1958 1
1959 5
1960 1
1961 2
1962 1
1963 2
1964 1
1966 3
1967 3
1968 3
1969 4
1970 2
1971 1
1972 2
1973 5
1974 5
1975 5
1976 7
1977 14
1978 12
1979 9
1980 9
1981 8
1982 6
1983 8
1984 14
1985 11
1986 6
1987 5
1988 10
1989 9
1990 8
1991 20
1992 20
1993 14
1994 15
1995 18
1996 19
1997 24
1998 24
1999 17
2000 20
2001 26
2002 26
2003 28
2004 40
2005 22
2006 35
2007 30
2008 48
2009 62
2010 45
2011 60
2012 63
2013 72
2014 72
2015 77
2016 73
2017 73
2018 68
2019 98
2020 112
2021 122
2022 128
2023 123
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

1,702 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
D'Haens G, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panés J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, Ferrante M. D'Haens G, et al. Among authors: berg s. Lancet. 2022 May 28;399(10340):2015-2030. doi: 10.1016/S0140-6736(22)00467-6. Lancet. 2022. PMID: 35644154 Clinical Trial.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Ferrante M, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panés J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, D'Haens G. Ferrante M, et al. Among authors: berg s. Lancet. 2022 May 28;399(10340):2031-2046. doi: 10.1016/S0140-6736(22)00466-4. Lancet. 2022. PMID: 35644155 Clinical Trial.
Genetic and phenotypic spectrum associated with IFIH1 gain-of-function.
Rice GI, Park S, Gavazzi F, Adang LA, Ayuk LA, Van Eyck L, Seabra L, Barrea C, Battini R, Belot A, Berg S, Billette de Villemeur T, Bley AE, Blumkin L, Boespflug-Tanguy O, Briggs TA, Brimble E, Dale RC, Darin N, Debray FG, De Giorgis V, Denecke J, Doummar D, Drake Af Hagelsrum G, Eleftheriou D, Estienne M, Fazzi E, Feillet F, Galli J, Hartog N, Harvengt J, Heron B, Heron D, Kelly DA, Lev D, Levrat V, Livingston JH, Marti I, Mignot C, Mochel F, Nougues MC, Oppermann I, Pérez-Dueñas B, Popp B, Rodero MP, Rodriguez D, Saletti V, Sharpe C, Tonduti D, Vadlamani G, Van Haren K, Tomas Vila M, Vogt J, Wassmer E, Wiedemann A, Wilson CJ, Zerem A, Zweier C, Zuberi SM, Orcesi S, Vanderver AL, Hur S, Crow YJ. Rice GI, et al. Among authors: berg s. Hum Mutat. 2020 Apr;41(4):837-849. doi: 10.1002/humu.23975. Epub 2020 Jan 14. Hum Mutat. 2020. PMID: 31898846 Free PMC article.
Exercise-based cardiac rehabilitation for adults after heart valve surgery.
Abraham LN, Sibilitz KL, Berg SK, Tang LH, Risom SS, Lindschou J, Taylor RS, Borregaard B, Zwisler AD. Abraham LN, et al. Among authors: berg sk. Cochrane Database Syst Rev. 2021 May 7;5(5):CD010876. doi: 10.1002/14651858.CD010876.pub3. Cochrane Database Syst Rev. 2021. PMID: 33962483 Free PMC article.
Author Reply.
van den Berg S, de Visser SJ, Timmers L, Hollak CEM. van den Berg S, et al. Value Health. 2022 Jan;25(1):158-159. doi: 10.1016/j.jval.2021.08.005. Epub 2021 Sep 21. Value Health. 2022. PMID: 35031095 Free article. No abstract available.
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Bakouny Z, Labaki C, Grover P, Awosika J, Gulati S, Hsu CY, Alimohamed SI, Bashir B, Berg S, Bilen MA, Bowles D, Castellano C, Desai A, Elkrief A, Eton OE, Fecher LA, Flora D, Galsky MD, Gatti-Mays ME, Gesenhues A, Glover MJ, Gopalakrishnan D, Gupta S, Halfdanarson TR, Hayes-Lattin B, Hendawi M, Hsu E, Hwang C, Jandarov R, Jani C, Johnson DB, Joshi M, Khan H, Khan SA, Knox N, Koshkin VS, Kulkarni AA, Kwon DH, Matar S, McKay RR, Mishra S, Moria FA, Nizam A, Nock NL, Nonato TK, Panasci J, Pomerantz L, Portuguese AJ, Provenzano D, Puc M, Rao YJ, Rhodes TD, Riely GJ, Ripp JJ, Rivera AV, Ruiz-Garcia E, Schmidt AL, Schoenfeld AJ, Schwartz GK, Shah SA, Shaya J, Subbiah S, Tachiki LM, Tucker MD, Valdez-Reyes M, Weissmann LB, Wotman MT, Wulff-Burchfield EM, Xie Z, Yang YJ, Thompson MA, Shah DP, Warner JL, Shyr Y, Choueiri TK, Wise-Draper TM; COVID-19 and Cancer Consortium. Bakouny Z, et al. Among authors: berg s. JAMA Oncol. 2023 Jan 1;9(1):128-134. doi: 10.1001/jamaoncol.2022.5357. JAMA Oncol. 2023. PMID: 36326731 Free PMC article.
CD2 Immunobiology.
Binder C, Cvetkovski F, Sellberg F, Berg S, Paternina Visbal H, Sachs DH, Berglund E, Berglund D. Binder C, et al. Among authors: berg s. Front Immunol. 2020 Jun 9;11:1090. doi: 10.3389/fimmu.2020.01090. eCollection 2020. Front Immunol. 2020. PMID: 32582179 Free PMC article. Review.
De nye kostrådene har metodiske mangler.
Kolby M, Bere E, Berg SH, Dankel SEN. Kolby M, et al. Among authors: berg sh. Tidsskr Nor Laegeforen. 2023 Nov 27;143(18). doi: 10.4045/tidsskr.23.0758. Print 2023 Dec 12. Tidsskr Nor Laegeforen. 2023. PMID: 38088281 Free article. Norwegian. No abstract available.
S.H. Berg svarer.
Berg SH. Berg SH. Tidsskr Nor Laegeforen. 2023 Sep 4;143(12). doi: 10.4045/tidsskr.23.0537. Print 2023 Sep 5. Tidsskr Nor Laegeforen. 2023. PMID: 37668120 Free article. Norwegian. No abstract available.
1,702 results